Literature DB >> 8589696

Localization of a gene for non-syndromic hearing loss (DFNA5) to chromosome 7p15.

G van Camp1, P Coucke, W Balemans, D van Velzen, C van de Bilt, L van Laer, R J Smith, K Fukushima, G W Padberg, R R Frants.   

Abstract

Progressive hearing loss affects approximately 50% of the elderly by the age of 80, and is most likely caused by an interaction of genetic and environmental factors. Identification of the genes responsible for hereditary hearing loss is therefore important. Families with pure genetic degenerative hearing disorders may be helpful as the same genes may be also involved in age-related hearing loss in general. In this study we have performed a genome search in an extended Dutch family with autosomal dominant progressive hearing loss starting in the high frequencies. The gene causing hearing loss in this family was localized to the short arm of chromosome 7, in a 15 cM interval between markers D7S493 and D7S632.

Entities:  

Mesh:

Year:  1995        PMID: 8589696     DOI: 10.1093/hmg/4.11.2159

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  21 in total

1.  A gene for fluctuating, progressive autosomal dominant nonsyndromic hearing loss, DFNA16, maps to chromosome 2q23-24.3.

Authors:  K Fukushima; N Kasai; Y Ueki; K Nishizaki; K Sugata; S Hirakawa; A Masuda; M Gunduz; Y Ninomiya; Y Masuda; M Sato; W T McGuirt; P Coucke; G Van Camp; R J Smith
Journal:  Am J Hum Genet       Date:  1999-07       Impact factor: 11.025

2.  Identification of a transcriptional repressor related to the noncatalytic domain of histone deacetylases 4 and 5.

Authors:  X Zhou; V M Richon; R A Rifkind; P A Marks
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

3.  A powerful and flexible statistical framework for testing hypotheses of allele-specific gene expression from RNA-seq data.

Authors:  Daniel A Skelly; Marnie Johansson; Jennifer Madeoy; Jon Wakefield; Joshua M Akey
Journal:  Genome Res       Date:  2011-08-26       Impact factor: 9.043

Review 4.  Nonsyndromic hearing impairment: unparalleled heterogeneity.

Authors:  G Van Camp; P J Willems; R J Smith
Journal:  Am J Hum Genet       Date:  1997-04       Impact factor: 11.025

Review 5.  Gasdermin family: a promising therapeutic target for cancers and inflammation-driven diseases.

Authors:  Danbin Wu; Yefei Chen; Yingxin Sun; Qing Gao; Bin Yu; Xijuan Jiang; Maojuan Guo
Journal:  J Cell Commun Signal       Date:  2020-03-31       Impact factor: 5.782

6.  A gene for autosomal dominant hearing impairment (DFNA14) maps to a region on chromosome 4p16.3 that does not overlap the DFNA6 locus.

Authors:  G Van Camp; H Kunst; K Flothmann; W McGuirt; J Wauters; H Marres; M Verstreken; I N Bespalova; M Burmeister; P H Van de Heyning; R J Smith; P J Willems; C W Cremers; M M Lesperance
Journal:  J Med Genet       Date:  1999-07       Impact factor: 6.318

7.  Methylation of the DFNA5 increases risk of lymph node metastasis in human breast cancer.

Authors:  Myoung Sook Kim; Cinthia Lebron; Jatin K Nagpal; Young Kwang Chae; Xiaofei Chang; Yiping Huang; Tony Chuang; Keishi Yamashita; Barry Trink; Edward A Ratovitski; Joseph A Califano; David Sidransky
Journal:  Biochem Biophys Res Commun       Date:  2008-03-17       Impact factor: 3.575

8.  In CEM cells the autosomal deafness gene dfna5 is regulated by glucocorticoids and forskolin.

Authors:  M S Webb; A L Miller; E Brad Thompson
Journal:  J Steroid Biochem Mol Biol       Date:  2007-05-24       Impact factor: 4.292

9.  Evidence for a founder mutation causing DFNA5 hearing loss in East Asians.

Authors:  Hong-Joon Park; Hyun-Ju Cho; Jeong-In Baek; Tamar Ben-Yosef; Tae-Jun Kwon; Andrew J Griffith; Un-Kyung Kim
Journal:  J Hum Genet       Date:  2009-11-13       Impact factor: 3.172

Review 10.  The genetic bases for non-syndromic hearing loss among Chinese.

Authors:  Xiao Mei Ouyang; Denise Yan; Hui Jun Yuan; Dai Pu; Li Lin Du; Don Yi Han; Xue Zhong Liu
Journal:  J Hum Genet       Date:  2009-02-06       Impact factor: 3.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.